| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Corresponding author: Beate Schwer, Weill Medical College of Cornell University, 1300 York Ave., New York, NY 10021., bschwer{at}mail.med.cornell.edu (E-mail)
Communicating editor: A. P. MITCHELL
| ABSTRACT |
|---|
The essential splicing factor Prp22 is a DEAH-box helicase that catalyzes the release of mRNA from the spliceosome. ATP hydrolysis by Prp22 is necessary but not sufficient for spliceosome disassembly. Previous work showed that mutations in motif III (635SAT637) of Prp22 that uncouple ATP hydrolysis from spliceosome disassembly lead to severe cold-sensitive (cs) growth defects and to impaired RNA unwinding activity in vitro. The cs phenotype of S635A (635AAT) can be suppressed by intragenic mutations that restore RNA unwinding. We now report the isolation and characterization of new intragenic mutations that suppress the cold-sensitive growth phenotypes of the T637A motif III mutation (SAA), the H606A mutation in the DEAH-box (DEAA), and the R805A mutation in motif VI (804QAKGRAGR811). Whereas the T637A and H606A proteins are deficient in releasing mRNA from the spliceosome at nonpermissive temperature in vitro, the suppressor proteins have recovered mRNA release activity. To address the mechanisms of suppression, we tested ATPase and helicase activities of Prp22 suppressor mutant proteins and found that the ability to unwind a 25-bp RNA duplex was not restored in every case. This finding suggests that release of mRNA from the spliceosome is less demanding than unwinding of a 25-bp duplex RNA; the latter reaction presumably reflects the result of several successive cycles of ATP binding, hydrolysis, and unwinding. Increasing the reaction temperature allows H606A and T637A to effect mRNA release in vitro, but does not restore RNA unwinding by T637A.
THE Saccharomyces cerevisiae PRP22 gene encodes an essential ATPase that functions at two distinct stages during the pre-mRNA splicing pathway. Prp22 is important for the second transesterification step, which entails cleavage at the 3' splice site and exon ligation, and it then catalyzes the release of mRNA from the spliceosome. Whereas the step 2 function of Prp22 is ATP independent, its role in spliceosome disassembly requires ATP hydrolysis (![]()
![]()
Prp22 is a member of the DExH-box family of nucleic acid-dependent phosphohydrolases and NTP-dependent helicases (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
The ability of Prp22 to hydrolyze ATP is necessary but not sufficient for Prp22's function in pre-mRNA splicing. Previous work showed that the hydroxyamino acids Ser635 and Thr637 in motif III (SAT) are important for coupling ATP hydrolysis to spliceosome disassembly and to RNA unwinding in vitro. The S635A mutation causes inviability at
30° and results in slow growth at 37°. A genetic screen for revertants of the growth defect of S635A at 30° led to the identification of intragenic suppressor mutations, all of which mapped within the ATPase domain of Prp22, which extends from residues 4661145 (![]()
![]()
The crystal structure of the DExH-box RNA helicase NS3 of hepatitis C virus (HCV) shows that motif III is located in a region that connects globular domain 1, which contains the GKT (motif I) and DExH (motif II) elements, to a second globular domain containing motif VI (QxxGRxxR; ![]()
![]()
![]()
- and
-phosphates of ATP, thereby bridging the two domains together in the ATP-bound state. They suggested that ATP hydrolysis leads to a conformational change that opens the cleft between the two domains and translocates the protein in a 3' to 5' direction along the polynucleotide.
This model invokes flexibility of the hinge region connecting the two domains, which may be impaired in the Prp22 mutant proteins S635A and T637A. Intragenic suppressor mutations likely identify structural elements that either interact with motif III or facilitate conformational steps required for Prp22's function in releasing mature RNA from the spliceosome. Such a conformational step can be measured as unwinding of an RNA duplex, and the V539I-suppressing mutation in S27 (S635A-V539I) did partially restore the ability to unwind a 25-bp RNA duplex to the S635A mutant protein (![]()
To further illuminate the correlation between the mRNA release function of Prp22 and its RNA helicase activity, we performed genetic screens for spontaneous intragenic suppressors of the cold-sensitive prp22-H606A, prp22-T637A, and prp22-R805A mutants. A pseudorevertant within motif III (SAA
SAS) and single-amino-acid changes at nine positions restored growth of prp22-T637A at the restrictive temperatures. All but two suppressor mutations of T637A mapped within the ATPase domain. Notably, some of the T637A suppressors and both of the H606A suppressor mutations mapped to residues that were mutated in suppressors of prp22-S635A. Biochemical analyses of three of the suppressor proteins revealed that they restored mRNA release activity to the T637A and H606A proteins. However, in one of the suppressor mutants, RNA unwinding activity was not revived, arguing that the helicase activity measured in vitro does not correspond strictly to the activity needed for spliceosome disassembly.
| MATERIALS AND METHODS |
|---|
Isolation of spontaneous suppressor mutations:
The mutant strains T637A, H606A, and R805A (MATa ura3-52 trp1-63 his3-
200 leu2
1 ade2-101 lys2-801 prp22::LEU2) contain the prp22-T637A, the prp22-H606A, or the prp22-R805A allele on CEN TRP1 plasmids (![]()
strain carrying p360-Prp22 (URA3 CEN PRP22). Trp+ transformants were selected and streaked onto agar medium containing 0.75 mg/ml 5-fluoroorotic acid (5-FOA) to select against the p360-Prp22 plasmid. The plates were incubated at 34°, a permissive temperature for all strains. Survivors resistant to 5-FOA were streaked to YPD medium and their growth at 37°, 34°, 30°, 25°, 19°, and 14° was compared to strains carrying wild-type PRP22 or the cs mutant alleles prp22-T637A, prp22-H606A, and prp22-R805A. We surmised that suppressor mutations in strains that grew better than the original cold-sensitive (cs) mutant were plasmid linked and due to changes within the PRP22 gene. Serial 10-fold dilutions of the intragenic suppressor mutants were spotted to YPD agar and incubated at 37°, 30°, 25°, and 14° (Fig 2). The complete nucleotide sequences were determined for each of the plasmid-linked prp22-T, prp22-H, and prp22-R alleles.
|
|
Expression and purification of recombinant Prp22 proteins:
Plasmid pET16b-Prp22 encodes an N-terminal His-tagged version of wild-type Prp22 under the control of a T7 promoter (![]()
The His-tagged Prp22 proteins were purified by Ni-agarose and phosphocellulose column chromatography as described (![]()
![]()
ATPase assay:
Reaction mixtures (20 µl) containing 40 mM Tris-HCl (pH 8.0), 2 mM DTT, 2 mM MgCl2, 1 mM [
-32P]ATP, 0.5 µg of poly(A), and Prp22 as specified were incubated for 30 min at 30°. The reactions were stopped by the addition of 280 µl of a 5% (w/v) suspension of activated charcoal in 20 mM phosphoric acid. The samples were incubated on ice for 10 min and the charcoal was recovered by centrifugation. 32P radioactivity in the supernatant was quantified by liquid scintillation counting. The results are average values from duplicate reaction mixes.
In vitro pre-mRNA splicing:
Yeast whole-cell extract from strain BJ2168 was prepared, using the liquid nitrogen method (![]()
![]()
400 fmol of 32P-GMP-labeled actin precursor RNA, 60 mM potassium phosphate, 2.5 mM MgCl2, 2 mM ATP, and 3% PEG8000. The reaction mixtures were incubated for 10 min at 23°, and then 50100 ng of wild-type or mutant Prp22 (glycerol gradient fractions) was added and incubation was continued for 15 min at either 23° or 30°. The reaction mixtures were halted by transfer to ice. Aliquots (90 µl) were layered onto 1540% glycerol gradients containing 20 mM HEPES (pH 6.5), 100 mM KCl, 2 mM MgCl2. The gradients were centrifuged at 4° for 12 hr at 35,000 rpm in a Sorvall TH641 rotor. Fractions (400 µl) were collected from the tops of the tubes. RNA was recovered from the gradient fractions by phenol extraction and ethanol precipitation. RNAs from alternate fractions were analyzed by electrophoresis through a 6% polyacrylamide (19:1) gel containing 7 M urea in TBE (89 mM Tris-borate, 2 mM EDTA). Radiolabeled RNA was visualized by autoradiographic exposure of the dried gel. The amounts of the mRNA products were quantified by scanning the gels using a STORM phosphorimager.
RNA unwinding assay:
Radiolabeled dsRNA helicase substrate was prepared as described previously (![]()
![]()
![]()
![]()
| RESULTS |
|---|
Intragenic missense mutations suppress the cold-sensitive growth phenotype of prp22-T637A, prp22-H606A, and prp22-R805A:
The mutant strains T637A, H606A, and R805A fail to grow at temperatures below 30° (T637A) or 20° (H606A, R805A). Previous work showed that the T637A protein is defective in catalyzing the release of mRNA from the spliceosome in vitro (![]()
Spontaneous suppressors were selected by growing the T637A, H606A, and R805A mutants at their respective restrictive temperatures (MATERIALS AND METHODS). We determined the intragenic mutations in each independent isolate of the prp22-T, prp22-H, and prp22-R suppressor mutants and found that suppression was due to a single coding change in every case (Fig 1). Growth of the suppressor mutants was compared to that of the wild-type PRP22 and the T637A, H606A, and R805A cells on rich medium (YPD) at 37°, 30°, 25°, and 14° (Fig 2).
Ten intragenic suppressors of the cs phenotype of T637A were selected. These were T2 (T637A-N803K), T4 (T637A-M853I), T5 (T637A-V633F), T6 (T637A-Q585H), T7 (T637A-G813S), T8 (T637S), T9 (T637A-H410P), T10 (T637A-G813S), T12 (T637A-A623D), and T13 (T637A-S399P). These strains all grew at 25° (the restrictive temperature for T637A) and several of the suppressor mutations (T2, T4, T7, and T8) even restored growth at 14° (Fig 2). The spontaneous suppressor mutations in H1 (H606A-A760V) and H2 (H606A-A623P) restored growth of H606A cells at 14° (Fig 2). The intragenic suppressor mutations in R1 (R805A-V730F) and R2 (R805A-S736I) restored growth of R805A cells at 14° (Fig 2).
Of the 15 intragenic suppressors, none entailed reversion of Ala637 to Thr, Ala606 to His, or Ala805 to Arg (Fig 1). However, one of the suppressors, prp22-T8, was a pseudorevertant in which Ala637 was changed to Ser. This result underscores the importance of both of the side-chain hydroxyls in motif III (SAT); the necessity for a Ser or Thr at position 635 in the Prp22 protein has been reported previously (![]()
In 13 of the 15 suppressors (T2, T4, T5, T6, T7, T8, T10, T12, H1, H2, R1, R2, and R4) the mutations were located within the ATPase/helicase domain of Prp22 (spanning amino acids 4651145; ![]()
![]()
The location of the suppressing mutations within the catalytic domain of Prp22 is instructive with respect to internal domain dynamics. Three independent suppressor mutations, T2 (N803K) and T7/T10 (G813S), mapped close to motif VI (804QRKGRAGR811; Fig 1). Motif VI residues Gln804, Gly807, Arg808, and Arg811 are essential for the in vivo function of Prp22, for spliceosome disassembly, and for ATP hydrolysis (![]()
![]()
Certain residues within Prp22 were changed multiple times in different intragenic suppressor mutants. For example, Ala623, located in the segment between the DEAH606 box and motif III, was changed to Asp in the T12 suppressor (T637A-A623D) and to Pro in the H2 suppressor (H606A-A623P; Fig 1). These same changes at Ala623 were found previously in the S16 (S635A-A623P) and the S32 (S635A-A623D) suppressors (![]()
None of the second-site mutations identified in R805A suppressors R1 (R805A-V730F), R2 (R805A-S736I), or R4 (R805A-V730F; Fig 1) had been found in any suppressor of S635A, T637A, or H606A, suggesting that the basis for cold sensitivity and the mechanism for suppression may be distinct for the R805A mutants.
Suppressor mutations restore spliceosome disassembly in vitro:
The suppressor proteins T4 (T637A-M853I), T7 (T637A-G813S), H1 (H606A-A760V), H2 (H606A-A623P), R1 (R805A-V730F), and R2 (R805A-S736I) were produced in bacteria as His-tagged fusions along with Prp22, T637A, H606A, and R805A. The T4, T7, H1, T637A, H606A, and Prp22 proteins were purified from soluble bacterial lysates by Ni-agarose and phosphocellulose chromatography followed by glycerol gradient sedimentation. SDS/PAGE analysis of the peak glycerol gradient fractions showed that the protein preparations were substantially pure (Fig 3). The H2, R1, R2, and R805A polypeptides were recovered exclusively in the insoluble fraction and were therefore not amenable to further analysis.
|
The cs phenotype of the T637A mutant correlates with the failure of the T637A protein to catalyze spliceosome disassembly in vitro (![]()
![]()
|
We also assayed the activity of the H606A mutant and the H1 (H606A-A760V) suppressor protein (Fig 4B). Whereas in reactions reconstituted with H606A 26% of the mature RNA was released, the H1 protein released 79% of mature RNA. Thus, the A760V change elicited a gain of function in spliceosome disassembly.
Release of mature RNA from the spliceosome is temperature dependent:
The permissive temperature for growth of the H606A mutant strain is
20°, whereas the T637A mutant does not form colonies at 25°. When the in vitro splicing assays were performed at 23°, H606A released 26% of ACT1 mRNA, whereas T637A released 11% of mRNA (Fig 4A and Fig B). To test whether the reaction temperature influenced spliceosome disassembly, we reconstituted the splicing reactions at 30° (Fig 4C). At 30°, wild-type Prp22 released 94% of mature RNA (not shown) and T637A and H606A released 77 and 85% of ACT1 mRNA, respectively (Fig 4C). Increasing the reaction temperature also further improved mRNA release by T4 from 44% at 23° to 82% at 30° (not shown).
We conclude that (i) the cs growth phenotype of T637A and H606A is likely due to the inability of the proteins to promote spliceosome disassembly at low temperature; (ii) secondary mutations suppress the cs growth defect by restoring spliceosome disassembly at low temperature; and (iii) increased thermal energy per se compensates for the functional defects of the T637A and H606A mutant proteins in spliceosome disassembly in vitro.
ATP hydrolysis by Prp22 mutant proteins:
Prp22 requires ATP hydrolysis to catalyze spliceosome disassembly (![]()
![]()
Using the protein preparations shown in Fig 3, we determined that the extent of ATP hydrolysis during a 30-min incubation at 30° was proportional to the amount of input enzyme (Fig 5A). In agreement with previous studies, the activity of the T637A mutant, which hydrolyzed 650 ATP min-1, was higher than that of wild-type Prp22 (430 min-1; Fig 5B). Similarly, the H606A and T4 proteins were more active, hydrolyzing 550 and 630 ATP min-1, respectively. The activities of T7 and H1 (160 and 150 ATP min-1) were
35% of wild-type Prp22.
|
ATP hydrolysis by Prp22 was stimulated 11-fold by poly(A) (Fig 5B). When we tested the extent to which the mutant proteins T637A, T4, T7, H606A, and H1 were stimulated by the presence of poly(A), we found that the basal levels of ATP hydrolysis by T637A, T4, and T7 were in a similar range as wild-type Prp22 (4060 ATP min-1). However, the basal ATPase activities of H606A and H1 were 4-fold higher, such that in the absence of poly(A), H606A and H1 hydrolyzed 160 and 190 ATP min-1, respectively (Fig 5B). These findings indicate that replacement of His606 in motif II by alanine renders ATP hydrolysis less dependent on an RNA cofactor, an observation that has been described for the NPH-II and the NS3 helicases (![]()
![]()
These findings indicate that the ATPase activity of Prp22, although necessary, is insufficient to effect spliceosome disassembly; i.e., there is not a strict correlation between the extent to which ATP can be hydrolyzed and the protein's function in mRNA release.
RNA unwinding by Prp22 mutant proteins:
We tested helicase activity of the T4 (T637A-M853I) and T7 (T637A-G813S) suppressor proteins, using an RNA substrate with a 25-bp duplex region and 82-nucleotide and 78-nucleotide 3' tails (Fig 6). The RNA substrate (25 fmol) was incubated without protein or in the presence of wild-type Prp22 and the mutant proteins for 30 min at 37°. The labeled product of the reaction comigrated during electrophoresis with the single-stranded species released by thermal denaturation of the substrate (Fig 6, lane
T). Single-stranded RNA was produced by wild-type Prp22 and 30 ng of protein unwound
50% of the dsRNA substrate (increasing the amount of protein did not yield more single-stranded product). In contrast, 30 ng of the T637A mutant unwound 5% of the substrate. The equivalent amount of the T4 (T637A-M853I) suppressor protein unwound 20%. We surmise that the M853I mutation suppresses the growth defect and the mRNA release deficiency of T637A by restoring partial RNA unwinding activity, a correlation that has been described for S27 (S635A-V539I), a suppressor mutant of S635A (![]()
|
On the other hand, the T7 (T637A-G813S) protein did not unwind the 25-bp RNA duplex at all. This suggests that the G813S mutation, which restored full spliceosome disassembly activity to T637A (Fig 4), suppressed by a mechanism that was not reflected in the assay measuring unwinding of a 25-bp duplex RNA.
| DISCUSSION |
|---|
This study illuminates the mechanism of Prp22 function in splicing in the following ways: (1) mRNA release is a temperature-dependent process; (2) gain-of-function mutations that suppress release-defective prp22-cs mutants map to the ATPase domain; (3) mRNA release activity does not strictly correlate with the activity of Prp22 to unwind a synthetic 25-bp duplex RNA.
The ATPase activity of Prp22 is necessary but not sufficient to effect mRNA release from the spliceosome. Prp22 couples the chemical energy to a conformational step, such as to disrupt or remodel macromolecular interactions in the spliceosome, thereby leading to mRNA release. Previous studies suggested that unwinding of a 3'-tailed 25-bp duplex RNA substrate by Prp22 in vitro is a direct "read-out" of its mRNA release activity (![]()
The spliceosomal target for Prp22 action is unknown and it remains to be seen whether Prp22 disrupts RNA/RNA interactions or whether it functions as an "RNPase" to disrupt RNA/protein interactions in the spliceosome. Studies of vaccinia virus NPH-II, a processive 3'-to-5' RNA helicase, have demonstrated that this DExH-box protein is capable of disrupting RNA-protein interactions in addition to RNA duplexes (![]()
![]()
![]()
![]()
![]()
![]()
The defects of the prp22-T637A and prp22-H606A mutants can be overcome in vivo and in vitro by secondary mutations in the ATPase domain. It is possible that the intragenic mutations restore the coupling of ATP hydrolysis to mRNA release by altering the internal domain dynamics. In this regard, it is informative to relate our mutational findings for Prp22 to structural information of the DExH helicase NS3 (![]()
![]()
![]()
90° retroflexion of the backbone at residue 640 (Fig 7). It can be seen that the essential surface-exposed side chains of motifs I and II face those in motif VI (Fig 7A) and that motif III is located on the segment connecting the two domains (Fig 7B). This model is consistent with a ratchet-like mechanism for RNA unwinding, proposed by ![]()
|
A subset of amino acids that were mutated in suppressors of T637A, H606A, and S635A are indicated in Fig 7C. It is plausible that mutations in the cleft directly affect the closing of the cleft upon ATP binding or its opening upon ATP hydrolysis. Other changes that restored growth of the mutant strains were found in amino acids that are modeled as being on the external surface of the protein and they may influence domain dynamics indirectly by affecting interactions of Prp22 with other spliceosomal components. Future studies will test the implications of this model.
Much is known about Prp22, the enzyme that catalyzes release of mature RNA from the spliceosome. However, understanding the mechanism of mRNA release in detail also requires the analysis of the macromolecular interactions within the spliceosome that are resolved or remodeled by Prp22. The analysis of extragenic suppressors of prp22-cs mutants may uncover potential spliceosomal targets (RNAs and/or proteins) for Prp22 action.
| ACKNOWLEDGMENTS |
|---|
We thank Chris Lima for all his help with the structural model. The Department of Microbiology and Immunology acknowledges the support of the William Randolph Hearst Foundation. This work was supported by grant GM50288 from the National Institutes of Health.
Manuscript received July 31, 2001; Accepted for publication November 5, 2001.
| LITERATURE CITED |
|---|
ANSARI, A. and B. SCHWER, 1995 SLU7 and a novel activity, SSF1, act during the PRP16-dependent step of yeast pre-mRNA splicing. EMBO J. 14:4001-4009[Medline].
CHEN, J. Y. F., L. STANDS, J. P. STALEY, R. R. JACKUPS, JR., and L. J. LATUS et al., 2001 Specific alterations of U1-C protein or U1 small nuclear RNA can eliminate the requirement of Prp28p, an essential DEAD-box splicing factor. Mol. Cell 7:227-232[Medline].
COMPANY, M., J. ARENAS, and J. ABELSON, 1991 Requirement of the RNA helicase-like protein PRP22 for release of messenger RNA from spliceosomes. Nature 349:487-493[Medline].
DE LA CRUZ, J., D. KRESSLER, and P. LINDER, 1999 Unwinding RNA in Saccharomyces cerevisiae: DEAD-box proteins and related families. Trends Biochem. Sci. 24:192-198[Medline].
GORBALENYA, A. E., E. V. KOONIN, A. P. DONCHEN, and V. M. BLINOV, 1989 Two related superfamilies of putative helicases involved in replication, recombination, repair and expression of DNA and RNA genomes. Nucleic Acids Res. 17:4713-4730
GROSS, C. H. and S. SHUMAN, 1995 Mutational analysis of vaccinia virus nucleoside triphosphate phosphohydrolase II, a DExH box RNA helicase. J. Virol. 69:4727-4736[Abstract].
GROSS, C. H. and S. SHUMAN, 1996 The QRxGRxGRxxxG motif of the vaccinia virus DExH box RNA helicase NPH-II is required for ATP hydrolysis and RNA unwinding but not for RNA binding. J. Virol. 70:1706-1713[Abstract].
HALL, M. C. and S. W. MATSON, 1999 Helicase motifs: the engine that powers DNA unwinding. Mol. Microbiol. 34:867-877[Medline].
HEILEK, G. M. and M. G. PETERSON, 1997 A point mutation abolishes the helicase but not the nucleoside triphosphatase activity of hepatitis C virus NS3 protein. J. Virol. 71:6264-6266[Abstract].
JANKOWSKY, J. and A. JANKOWSKY, 2000 The DExH/D protein family database. Nucleic Acids Res. 28:333-334
JANKOWSKY, E., C. H. GROSS, S. SHUMAN, and A. M. PYLE, 2001 Active disruption of an RNA-protein interaction by a DExH/D RNA helicase. Science 291:121-125
KIM, D. W., J. KIM, Y. GWACK, J. H. HAN, and J. CHOE, 1997 Mutational analysis of hepatitis C virus RNA helicase. J. Virol. 71:9400-9409[Abstract].
KIM, J. L., K. A. MORGENSTERN, J. P. GRIFFITH, M. D. DWYER, and J. A. THOMSON et al., 1998 Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding. Structure 6:89-100[Medline].
KISTLER, A. L. and C. GUTHRIE, 2001 Deletion of MUD2, the yeast homologue of U2AF65, can bypass the requirement for Sub2, an essential spliceosomal ATPase. Genes Dev. 15:42-49
LEE, C. G. and J. HURWITZ, 1992 A new RNA helicase isolated from HeLa cells that catalytically translocates in the 3' to 5' direction. J. Biol. Chem. 267:4398-4407
LEE, C. G., K. A. CHANG, M. I. KURODA, and J. HURWITZ, 1997 The NTPase/helicase activities of Drosophila maleless, an essential factor in dosage compensation. EMBO J. 16:2671-2681[Medline].
MARTINS, A., C. H. GROSS, and S. SHUMAN, 1999 Mutational analysis of vaccinia virus nucleoside triphosphate phosphohydrolase I, a DNA-dependent ATPase of the DExH box family. J. Virol. 73:1302-1308
NICHOLLS, A., K. A. SHARP, and B. HONIG, 1991 Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins Struct. Funct. Genet. 11:281-296[Medline].
SÁNCHEZ, R., U. PIEPER, N. MIRKOVIC, P. I. W. DEBAKKER, and E. WITTENSTEIN et al., 2000 MODBASE: a database of annotated comparative protein structure models. Nucleic Acids Res. 28:250-253
SCHNEIDER, S. and B. SCHWER, 2001 Functional domains of the yeast splicing factor Prp22p. J. Biol. Chem. 276:21184-21191
SCHWER, B., 2001 A new twist on RNA helicases: DExH/D box proteins as RNPases. Nat. Struct. Biol. 8:113-116[Medline].
SCHWER, B. and C. H. GROSS, 1998 Prp22, a DExH-box RNA helicase, plays two distinct roles in yeast pre-mRNA splicing. EMBO J. 17:2086-2094[Medline].
SCHWER, B. and T. MESZAROS, 2000 RNA helicase dynamics in pre-mRNA splicing. EMBO J. 19:6582-6591[Medline].
WAGNER, J. D. O., E. JANKOWSKY, M. COMPANY, A. M. PYLE, and J. N. ABELSON, 1998 The DEAH-box protein PRP22 is an ATPase that mediates ATP-dependent mRNA release from spliceosomes and unwinds RNA duplexes. EMBO J. 17:2926-2937[Medline].
YAO, N., T. HESSON, M. CABLE, Z. HONG, and A. D. KWONG et al., 1997 Structure of the hepatitis C virus RNA helicase domain. Nat. Struct. Biol. 4:463-467[Medline].
This article has been cited by other articles:
![]() |
N. Tanaka, A. Aronova, and B. Schwer Ntr1 activates the Prp43 helicase to trigger release of lariat-intron from the spliceosome Genes & Dev., September 15, 2007; 21(18): 2312 - 2325. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Aronova, D. Bacikova, L. B. Crotti, D. S. Horowitz, and B. Schwer Functional interactions between Prp8, Prp18, Slu7, and U5 snRNA during the second step of pre-mRNA splicing RNA, September 1, 2007; 13(9): 1437 - 1444. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Granneman, K. A. Bernstein, F. Bleichert, and S. J. Baserga Comprehensive Mutational Analysis of Yeast DEXD/H Box RNA Helicases Required for Small Ribosomal Subunit Synthesis Mol. Cell. Biol., February 15, 2006; 26(4): 1183 - 1194. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Schneider, E. Campodonico, and B. Schwer Motifs IV and V in the DEAH Box Splicing Factor Prp22 Are Important for RNA Unwinding, and Helicase-defective Prp22 Mutants Are Suppressed by Prp8 J. Biol. Chem., March 5, 2004; 279(10): 8617 - 8626. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. EDWALDS-GILBERT, D.-H. KIM, E. SILVERMAN, and R.-J. LIN Definition of a spliceosome interaction domain in yeast Prp2 ATPase RNA, February 1, 2004; 10(2): 210 - 220. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Vincent, Q. Wang, S. Jay, K. Hobbs, and B. C. Rymond Genetic Interactions With CLF1 Identify Additional Pre-mRNA Splicing Factors and a Link Between Activators of Yeast Vesicular Transport and Splicing Genetics, July 1, 2003; 164(3): 895 - 907. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-G. Lee RH70, a Bidirectional RNA Helicase, Co-purifies with U1snRNP J. Biol. Chem., October 11, 2002; 277(42): 39679 - 39683. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Martin, S. Schneider, and B. Schwer Prp43 Is an Essential RNA-dependent ATPase Required for Release of Lariat-Intron from the Spliceosome J. Biol. Chem., May 10, 2002; 277(20): 17743 - 17750. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Schneider, H.-R. Hotz, and B. Schwer Characterization of Dominant-negative Mutants of the DEAH-box Splicing Factors Prp22 and Prp16 J. Biol. Chem., May 3, 2002; 277(18): 15452 - 15458. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |